Intellectia Ai
Published September 4, 2026 · Updated September 6, 2026
Clearmind Medicine initiates Phase IIa trial for AUD treatment - Intellectia AI
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic.
Read the full story at Intellectia Ai
Surfaced by this Google Alert
- Psychedelic biotech
